BIOCRYST PHARMACEUTICALS INC 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jul 13, 2005
Insider Transaction Report
Form 4
BENNETT J CLAUDE
DirectorPresident
Transactions
- Exercise/Conversion
Stock Option
2005-07-13$1.04/sh−623$648→ 434,173 totalExercise: $1.04From: 2003-12-11Exp: 2012-12-10→ Common Stock (623 underlying) - Exercise/Conversion
Common Stock
2005-07-13$3.59/sh+3,800$13,642→ 23,269 total - Exercise/Conversion
Common Stock
2005-07-13$1.04/sh+623$648→ 25,788 total - Exercise/Conversion
Stock Option
2005-07-13$3.59/sh−3,800$13,642→ 437,846 totalExercise: $3.59From: 2002-12-12Exp: 2011-12-11→ Common Stock (3,800 underlying) - Exercise/Conversion
Common Stock
2005-07-13$1.18/sh+1,896$2,237→ 25,165 total - Exercise/Conversion
Common Stock
2005-07-13$0.87/sh+3,050$2,654→ 28,838 total - Exercise/Conversion
Stock Option
2005-07-13$0.87/sh−3,050$2,654→ 434,796 totalExercise: $0.87From: 2003-02-03Exp: 2013-02-03→ Common Stock (3,050 underlying) - Exercise/Conversion
Stock Option
2005-07-13$1.18/sh−1,896$2,237→ 432,277 totalExercise: $1.18From: 2003-08-05Exp: 2012-08-04→ Common Stock (1,896 underlying)
Footnotes (1)
- [F1]Exercise and hold only